Acorda Therapeutics Inc Insider-Eigentum
Was ist das Insider-Eigentum von Acorda Therapeutics Inc?
Insider-Eigentum von Acorda Therapeutics Inc ist 0.69%
Was ist die Definition von Insider-Eigentum?
Das Insider-Eigentum wird berechnet als die Gesamtzahl der Aktien, die sich im Besitz von Insidern (Anteilseignern, die mehr als 5% der Gesellschaft oder eines leitenden Angestellten oder Direktors der Gesellschaft besitzen), dividiert durch die Gesamtzahl der ausstehenden Aktien.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider-Eigentum von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Acorda Therapeutics Inc
Was macht Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Unternehmen mit insider-eigentum ähnlich Acorda Therapeutics Inc
- Splunk Inc hat Insider-Eigentum von 0.68%
- Broadridge Solutions hat Insider-Eigentum von 0.68%
- Mondi plc hat Insider-Eigentum von 0.68%
- First Republic Bank hat Insider-Eigentum von 0.68%
- Quest Diagnostics hat Insider-Eigentum von 0.68%
- Oshkosh Corp hat Insider-Eigentum von 0.68%
- Acorda Therapeutics Inc hat Insider-Eigentum von 0.69%
- Praxis Precision Medicines hat Insider-Eigentum von 0.69%
- The Weir Plc hat Insider-Eigentum von 0.69%
- The City of London Investment Trust Plc hat Insider-Eigentum von 0.69%
- Blueprint Medicines Corp hat Insider-Eigentum von 0.69%
- Primerica Inc hat Insider-Eigentum von 0.69%
- Starr Peak Exploration hat Insider-Eigentum von 0.69%